Benzonatate Capsule
Product Images NDC 71335-2590

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 71335-2590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Forluma For Benzonatate (52dc3ff3 F01b 4820 Ba1e B043a5b2c49a 01)

Structure Forluma For Benzonatate (52dc3ff3 F01b 4820 Ba1e B043a5b2c49a 01)
Not available.*
FDA Label Image

Label (Lbl713352590)

Label (Lbl713352590)
Each softgel contains Benzonatate, USP 200 mg. These soft gelatin capsules are child-resistant and should be kept out of reach of children. They should be dispensed in a tight, child-resistant container and stored at 20° to 25°C (68° to 77°F) to protect from light. This medication is available in a package containing 30 capsules and is manufactured by Bryant Ranch Prepack, Inc. and Zydus Lifesciences Ltd. in Burbank, CA, USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.